Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Change in Cash (2020 - 2025)

Historic Change in Cash for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to -$1.3 million.

  • HCW Biologics' Change in Cash fell 72287.59% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98688.0, marking a year-over-year increase of 10096.54%. This contributed to the annual value of $1.1 million for FY2024, which is 10576.29% up from last year.
  • As of Q3 2025, HCW Biologics' Change in Cash stood at -$1.3 million, which was down 72287.59% from $1.3 million recorded in Q2 2025.
  • HCW Biologics' 5-year Change in Cash high stood at $10.8 million for Q3 2022, and its period low was -$10.9 million during Q2 2023.
  • Its 5-year average for Change in Cash is -$387311.8, with a median of -$1.6 million in 2021.
  • As far as peak fluctuations go, HCW Biologics' Change in Cash soared by 49922.57% in 2022, and later crashed by 82947.68% in 2025.
  • Over the past 5 years, HCW Biologics' Change in Cash (Quarter) stood at -$3.4 million in 2021, then dropped by 14.83% to -$3.9 million in 2022, then tumbled by 95.64% to -$7.6 million in 2023, then skyrocketed by 148.21% to $3.7 million in 2024, then crashed by 136.51% to -$1.3 million in 2025.
  • Its last three reported values are -$1.3 million in Q3 2025, $1.3 million for Q2 2025, and -$3.6 million during Q1 2025.